P-356 Addition of SRL172 (Mycobacterium vaccae) to standard chemotherapy in small cell lung cancer (SCLC) confers no survival benefit: Results of a randomised multicentre study

✍ Scribed by Harper-Wynne, Catherine L.; Sumpter, Kate; O'Brien, Mary E.R.; Johnson, Peter; Bass, Rachel; Goldie, Tina; Norton, Alison; Ross, Paul; Ford, Hugo; Kennard, David

• Book ID: 118572056
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 374 KB
• Volume: 41
• Category: Article
• ISSN: 0169-5002
• DOI: 10.1016/s0169-5002(03)92324-5